Chamber and committees

Since 2016, the Farming Opportunities for New Entrants (FONE) Group has helped facilitate entry to over 80 new entrants across more than 8,000 hectares of publicly owned land in Scotland.

Instigated by the FONE Group and funded by the Scottish Government, the Scottish Land Matching Service (SLMS) provides a platform for opportunities for the next generation of farmers and crofters, by engaging with those seeking or offering joint venture arrangements in relation to land and facilities. To date the SLMS has facilitated over 300 individuals and formally matched over 50 joint-ventures, some of which includes publicly owned land.

Replacement of the Marine Evacuation System is scheduled to begin in May 2025.

No. The Scottish Government is not responsible for monitoring or enforcing compliance with health and safety legislation, which is a reserved matter.

The Campbeltown service operated on 146 days between June 2021 and September 2022. There were no services beyond this date due to the need to withdraw the route since that time.

There has been regular communication between the Scottish Government and the Scottish Prison Service on HMP Highland, including time-scales for completion, since 2011, in line with updates to the Infrastructure Investment Plan.

• In December 2011 the Scottish Government was updated that completion dates for HMP Highland were uncertain.
• In October 2015 the Scottish Government was updated that estimated operational date was 2019.
• In September 2016 the Scottish Government was updated that estimated operational date was 2020.
• In July 2018 the Scottish Government was updated that estimated operational date was 2021.
• In April 2019 the Scottish Government was updated that estimated operational date was 2023.
• In September 2020 the Scottish Government was updated that estimated operational date was 2024.
• In September 2022 the Scottish Government was updated that estimated operational date was 2025.
• In February 2024 the Scottish Government was updated that the most likely time-scale for construction completion was 2026.

From the date of the charter to 30 September 2024, the Scottish Government has provided funding to CalMac of £16.2m. Under the Clyde and Hebrides Contract Extension, the costs were included as part of the overall funding and therefore were not paid separately.

Discussions regarding a further extension between CalMac and Pentland Ferries are currently ongoing therefore final costings have yet to be received.

There are currently three Energy from Waste (EfW) sites currently in construction and commissioning and SEPA keeps the Scottish Government updated about their development.

With respect to community consent, these facilities require planning consent from the relevant local authority and a permit from SEPA. Both the planning process and SEPA permitting process include formal consultation processes.

For EfW permits, SEPA consults the public twice: firstly at an early stage of the application and again on SEPA’s draft determination and draft decision document. This process has been followed for all EfW permits to date. Some EfW facilities also have regular liaison meetings with their local community and SEPA attends when invited.

Permits plus compliance and monitoring data are published by SEPA on its public register and EfW operators are also required, via the permit, to publish their monitoring data on their own website. There is also a 24 hour pollution hotline which members of the public can use to inform SEPA of any issues associated with an EfW facility.

Scottish Enterprise, our national economic development agency, works with businesses in Scotland to create high-value jobs, enable innovation, boost productivity and attract investment. Scottish Enterprise would be happy to engage with Clowes Developments to discuss the support available to them going forward.

However, any decision about future development on the site is a matter for Glasgow City Council in the first instance.

As set out in the answer to questions S6W-35253 and S6W-35256 on 11 March 2025, as part of the NHS Scotland Board Annual Review process, the feedback obtained from Area Partnership forums highlighted safety related concerns from a wide range of Agenda for Change colleagues on any reduction to the working week in 2025.

Extensive research was undertaken on the impact of the first 30 minute reduction of the working week for Agenda for Change staff. This included its impact on maintaining system performance, meeting legislative requirements around safe staffing and the delivery of planned initiatives to support service recovery. On review of this research it was clear that, to avoid unacceptable levels of risk to service resilience and patient safety, introducing the remaining hour on 1 April 2026 would be the most appropriate option.

To confirm, there is no delay in the implementation of the reduction of the working week to 36 hours for Agenda for Change staff. It was always the intention to use the initial 30 minute reduction in April 2024 as an opportunity to learn and assess how best to move forward with any further reduction in the working week.

The Scottish Government is therefore committed to fully implementing the remaining 60 minute reduction in the working week for all Agenda for Change staff on 1 April 2026. This will facilitate patient and staff safety, support the continued recovery of services and avoid any extra burden for our workforce.

This implementation date of 1 April 2026 remains fully in line with the commitment made as part of the 2023-24 Agenda for Change pay settlement and the Scottish Government’s Programme for Government.

All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The data for the number of people being prescribed Ozempic by year in Scotland can be found in the following table.

To note: the table contains prescribing data for Ozempic only and does not include data for those being prescribed other branded semaglutide medicines.